Positive Phase III Results for Venclexta Combination in Acute Myeloid Leukemia Presented At EHA 2020
– Phase III VIALE-A study showed Venclexta plus azacitidine helped people with the most common type of aggressive adult leukemia…
Pharmaceuticals, Biotechnology and Life Sciences
– Phase III VIALE-A study showed Venclexta plus azacitidine helped people with the most common type of aggressive adult leukemia…
LONDON–(BUSINESS WIRE)–#AlprazolamMarket–Technavio has been monitoring the alprazolam market and it is poised to grow by USD 90.33 million during 2020-2024,…
GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Now Approved for the Prevention of HPV-Related Cervical, Vaginal, Vulvar, Anal, Oropharyngeal and Other…
Denali Therapeutics and Sanofi have paused clinical studies with small molecule RIPK1 inhibitor DNL747 in Alzheimer’s disease and ALS, due to emerging evidence that higher levels of target inhibition may be required for maximizing efficacy, and certain challenges.
ViiV Healthcare Friday said that the US Food and Drug Administration (FDA) has approved Tivicay PD (dolutegravir) tablets for oral suspension, used combined with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in certain young patients.
– SUNFISH Part 1 showed risdiplam significantly improved motor function after 24 months of treatment in people aged 2-25 years…
– SUNFISH Part 1 showed risdiplam significantly improved motor function after 24 months of treatment in people aged 2-25 years…
New Analyses Show Statistically Significant Differences from Placebo for the 8 mg and 12 mg Twice-Daily Cohorts Achieving a SALT…
New Analyses Show Statistically Significant Differences from Placebo for the 8 mg and 12 mg Twice-Daily Cohorts Achieving a SALT…
Milton High School Senior Shreya Ramesh Achieves Global Excellence in Scientific Research ATLANTA–(BUSINESS WIRE)–Shreya Ramesh, a Milton High School senior,…